These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17110383)
1. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. Borgoño CA; Michael IP; Shaw JL; Luo LY; Ghosh MC; Soosaipillai A; Grass L; Katsaros D; Diamandis EP J Biol Chem; 2007 Jan; 282(4):2405-22. PubMed ID: 17110383 [TBL] [Abstract][Full Text] [Related]
2. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. Michael IP; Sotiropoulou G; Pampalakis G; Magklara A; Ghosh M; Wasney G; Diamandis EP J Biol Chem; 2005 Apr; 280(15):14628-35. PubMed ID: 15713679 [TBL] [Abstract][Full Text] [Related]
3. Expression and enzymatic characterization of recombinant human kallikrein 14. Rajapakse S; Takahashi T Zoolog Sci; 2007 Aug; 24(8):774-80. PubMed ID: 18217483 [TBL] [Abstract][Full Text] [Related]
4. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer. Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475 [TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. Rajapakse S; Ogiwara K; Takano N; Moriyama A; Takahashi T FEBS Lett; 2005 Dec; 579(30):6879-84. PubMed ID: 16337200 [TBL] [Abstract][Full Text] [Related]
6. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Mikolajczyk SD; Millar LS; Kumar A; Saedi MS Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387 [TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse glandular kallikrein 24 expressed in testicular Leydig cells. Matsui H; Takano N; Takahashi T Int J Biochem Cell Biol; 2005 Nov; 37(11):2333-43. PubMed ID: 15985384 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. Magklara A; Mellati AA; Wasney GA; Little SP; Sotiropoulou G; Becker GW; Diamandis EP Biochem Biophys Res Commun; 2003 Aug; 307(4):948-55. PubMed ID: 12878203 [TBL] [Abstract][Full Text] [Related]
9. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Felber LM; Borgoño CA; Cloutier SM; Kündig C; Kishi T; Ribeiro Chagas J; Jichlinski P; Gygi CM; Leisinger HJ; Diamandis EP; Deperthes D Biol Chem; 2005 Mar; 386(3):291-8. PubMed ID: 15843175 [TBL] [Abstract][Full Text] [Related]
10. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins. Obiezu CV; Michael IP; Levesque MA; Diamandis EP Biol Chem; 2006 Jun; 387(6):749-59. PubMed ID: 16800736 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6. Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340 [TBL] [Abstract][Full Text] [Related]
12. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. Lövgren J; Airas K; Lilja H Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640 [TBL] [Abstract][Full Text] [Related]
13. KLK14 interactions with HAI-1 and HAI-2 serine protease inhibitors: A molecular dynamics and relative free-energy calculations study. Solís-Calero C; Carvalho HF Cell Biol Int; 2017 Nov; 41(11):1246-1264. PubMed ID: 28817220 [TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Hooper JD; Bui LT; Rae FK; Harvey TJ; Myers SA; Ashworth LK; Clements JA Genomics; 2001 Apr; 73(1):117-22. PubMed ID: 11352573 [TBL] [Abstract][Full Text] [Related]
16. Major role of human KLK14 in seminal clot liquefaction. Emami N; Deperthes D; Malm J; Diamandis EP J Biol Chem; 2008 Jul; 283(28):19561-9. PubMed ID: 18482984 [TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Stefansson K; Brattsand M; Ny A; Glas B; Egelrud T Biol Chem; 2006 Jun; 387(6):761-8. PubMed ID: 16800737 [TBL] [Abstract][Full Text] [Related]
18. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417 [TBL] [Abstract][Full Text] [Related]
19. Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14. de Veer SJ; Swedberg JE; Parker EA; Harris JM Biol Chem; 2012 Apr; 393(5):331-41. PubMed ID: 22505516 [TBL] [Abstract][Full Text] [Related]
20. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer. Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]